Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-01-07 @ 3:44 AM
Study NCT ID:
NCT04394650
Status:
COMPLETED
Last Update Posted:
2024-07-26
First Post:
2020-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
Sponsor:
Juno Therapeutics, a Subsidiary of Celgene
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CC-98633-MM-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None